Jeff Yass’s Kezar Life Sciences KZR Stock Holding History

Jeff Yass’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,800	Closed	-$384K	–	14025
2026 Q1	$384K	Buy	+51,800	New	+$337K	﹤0.01%	10309
2023 Q2	–	Sell	-1,850	Closed	-$57.9K	–	12664
2023 Q1	$57.9K	Buy	+1,850	New	+$107K	﹤0.01%	11628
2022 Q3	–	Sell	-12,420	Closed	-$1.03M	–	13704
2022 Q2	$1.03M	Buy	12,420 +1,960	+19%	+$173K	﹤0.01%	6483
2022 Q1	$1.74M	Buy	+10,460	New	+$1.5M	﹤0.01%	5793
2021 Q2	–	Sell	-1,190	Closed	-$71K	–	12950
2021 Q1	$71K	Buy	+1,190	New	+$69.6K	﹤0.01%	11966
2020 Q3	–	Sell	-5,130	Closed	-$266K	–	10868
2020 Q2	$266K	Buy	+5,130	New	+$259K	﹤0.01%	8564

Jeff Yass's KZR Position: Q4 2024 in Review

Jeff Yass sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 1,259 shares — an estimated $9.38K sold.

Jeff Yass first reported a position in KZR in Q1 2020 and held it in 16 quarters. The position peaked at $1.1M in Q1 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.

Jeff Yass reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
Jeff Yass sold 1,259 Kezar Life Sciences shares in Q4 2024, an estimated $9.38K.
Jeff Yass first reported a position in Kezar Life Sciences in Q1 2020 and held it in 16 quarters.
Jeff Yass's Kezar Life Sciences position peaked at $1.1M in Q1 2022.
43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.